Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Annals of Medicine Volume 54, 2022 - Issue 1

Submit an article Journal homepage

Open access

2,813

Views

CrossRef citations to date

Altmetric

Oncology

Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy

Christoph Minichsdorfera Department of Medicine I & CCC, Division of Oncology, Medical University of Vienna, Wien, Austria

Andreas Gleissb Medical University of Vienna, Center for Medical Statistics, Informatics, and Intelligent Systems Institute of Clinical Biometrics, Wien, Austria

Marie-Bernadette Aretinc Pharmacy Department, Vienna General Hospital – Medical University Campus, Wien, Austria

Manuela Schmidingerd Department of Urology, Medical University of Vienna, Wien, Austria

Thorsten Fueredera Department of Medicine I & CCC, Division of Oncology, Medical University of Vienna, Wien, AustriaCorrespondence[email protected]

Pages 1339-1349 | Received 16 Sep 2021, Accepted 21 Apr 2022, Published online: 10 May 2022

Cite this article
https://doi.org/10.1080/07853890.2022.2070660
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Dehua Liao, Lun Yu, Shanshan Chen, Ni Liu, Jingyi Tang & Nong Yang. (2023) The safety profile of EGFR/ALK-TKIs administered immediately before or after ICIs in advanced NSCLC. International Immunopharmacology 116, pages 109787.
Crossref

Susanne Krome. (2022) Immuntherapie mit PD-1-/PD-L1-Antikörpern. Onkologische Welt 13:05, pages 303-304.
Crossref

Xiangxing Liu, Jiaojiao Zhang, Keqing Feng, Simin Wang, Liming Chen, Suping Niu, Qian Lu & Yi Fang. (2022) Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis. Frontiers in Pharmacology 13.
Crossref

Zhengyi Lyu, Siyi Zheng, Shuxin Tian, Yunmeng Nie, Rui Huang, Hong Zhao, Lihua Lou, Guoyin Kai, Haiyong Ye & Yi Liang. (2022) Treatment-Related Adverse Events of PD-1 or PD-L1 Inhibitors for Triple Negative Breast Cancer Patients: A Systematic Review and Meta-Analysis. SSRN Electronic Journal.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references